Skip to main content
Log in

Veränderungen der Blut-Liquorschranke für Serumproteine bei Kindern mit akuter lymphatischer Leukämie

Changes of blood-CSF barrier for serum proteins in children with acute lymphoblastic leukemia

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The blood-CSF barrier inhibits permeation of most chemotherapeutic agents into the central nervous system (CNS). The influence of systemic chemotherapy and prohylactic CNS irradiation on the permeability of the blood-CSF barrier was studied in 49 children treated for acute lymphoblastic leukemia (ALL) or non-Hodgkin's lymphoma.

To study the permeability of the blood-CSF barrier under treatment according to BFM-ALL protocols, nephelometric determinations of albumin, immunoglobulin G (IgG), and alpha-2-macroglobulin in serum and CSF and total protein in CSF were performed at several time intervals during chemotherapy and prophylactic cranial irradiation.

During systemic induction chemotherapy, no significant changes of blood-CSF barrier could be observed. In contrast, in the course of prophylactic CNS irradiation and intrathecal methotrexate application, a significant elevation of albumin, alpha-2-macroglobulin and total protein in CSF, and a significant decrease of blood: CSF ratios for albumin and alpha-2-macroglobulin were observed. IgG did not change significantly.

After prophylactic CNS treatment and during maintenance chemotherapy protein concentrations and blood:CSF ratios gradually returned to normal range. This normalization was accelerated by cortisone treatment during the reinduction period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Egg-Olofsson O, Link H, Wigertz A (1981) Concentrations on CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CNS in normal subjects from the age of 6 months to 30 years. Acta Paediatr Scand 70:167–170

    Google Scholar 

  2. Ettinger LJ, Chervinsky DS, Freeman AI, Creaven PJ (1982) Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and Non-Hodgkin's lymphoma. Cancer 50:1676–1682

    Google Scholar 

  3. Felgenhauer K (1974) Protein size and cerebrospinal fluid composition. Klin Wochenschr 52:1153–1164

    Google Scholar 

  4. Felgenhauer K, Schliep G, Rapic N (1976) Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system. J Neurol Sci 30:113–128

    Google Scholar 

  5. Greig NH (1984) Chemotherapy of brain metastases: Current status. Canc Treat Rev 11:157–186

    Google Scholar 

  6. Habermalz I, Habermalz HJ, Stephani Z, Henze G, Riehm H, Hanefeld F (1983) Cranial computed tomography of 64 children in continuous complete remission of Leukemia. I: Relations to therapy modalities. Neuropediatrics 14:144–148

    Google Scholar 

  7. Hanefeld F, Riehm H (1980) Therapy of acute lymphoblastic leukemia in childhood: Effects on the central nervous system. Neuropediatrics 11:3–16

    Google Scholar 

  8. Janka GE (1982) Hochdosierte und mittelhochdosierte Methotrexat-Therapie bei Kindern mit Leukämie und soliden Tumoren: Bedeutung der Bestimmung von Blut- und Liquorkonzentrationen für die Verlaufskontrolle. Habilitationsschrift, München

    Google Scholar 

  9. Karitzky D (1975) Die quantitative Bestimmung einzelner Liquorproteine in der Diagnostik entzündlicher ZNS-Erkrankungen im Kindesalter. Europ J Pediat 121:51–57

    Google Scholar 

  10. Liappis N, Jäckl A (1976) Normalbereich der mittels radialer Immundiffusion bestimmten Albumin- und IgG-Konzentration im Liquor cerebrospinals von Kindern. Klin Pädiatr 188:267–270

    Google Scholar 

  11. Link H, Tibbling G (1977) Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand J Clin Lab Invest 37:391–396

    Google Scholar 

  12. Link H, Tibbling G (1977) Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 37:397–401

    Google Scholar 

  13. Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP (1982) Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: The factor of the blood-brain barrier. Proc Natl Acad Sci USA 79:4420–4423

    Google Scholar 

  14. Oldendorf WH (1974) Lipid solubility and drug penetration of the blood-brain barrier. Proc Soc Exp Biol Med 147:813–816

    Google Scholar 

  15. Poplack DG, Bleyer WA, Wood JH, Kostolich M, Savitch JL, Ommaya AK (1977) A primate model for study of methotrexate pharmacokinetics in the central nervous system. Cancer Research 37:1982–1985

    Google Scholar 

  16. Price RA (1979) Histopathology of CNS leukemia and complications of therapy. Am J Pediat Haematol Oncol 1:21–30

    Google Scholar 

  17. Rating D, Siemes H, Siegert M, Gadner H, Hanefeld F, Riehm H (1978) Induktionsbehandlung der akuten lymphoblastischen Leukämie (ALL): Störung der Blut-Hirn-Liquorschrankenfunktion und Beziehungen zum Encephalopathie-Syndrom. Klin Wochenschr 56:473–474

    Google Scholar 

  18. Riehm H, Gadner H, Henze G, Jobke A, Langermann HJ, Lasson U, Ludwig R, Müller-Weihrich St, Niethammer D, Ritter J, Schellong G, Wahlen W (1982) Therapie der akuten Leukämien beim Kind. In: Scheurlen TP, Pees HW (Hrsg) Aktuelle Therapie bösartiger Blutkrankheiten. Springer, Berlin Heidelberg New York

    Google Scholar 

  19. Schliep G, Felgenhauer K (1974) The alpha-2-macroglobulin level in cerebrospinal fluid; a parameter for the condition of the blood-CSF barrier. J Neurol 207:171–181

    Google Scholar 

  20. Schliep G, Felgenhauer K (1978) Rapid determination of proteins in serum and cerebrospinal fluid by lasernephelometry. J Clin Chem Clin Biochem 16:631–635

    Google Scholar 

  21. Siemes H, Rating D, Siegert M, Hanefeld F, Müller St, Gadner H, Riehm H (1980) Changes of CSF-protein pattern in children with acute lymphoblastic leukemia during prophylactic CNS therapy (Berlin procotol) Med Ped Oncol 8:25–34

    Google Scholar 

  22. Siemes H, Siegert M, Hanefeld F (1981) Occurence of oligoclonal gammaglobulin in the CSF of children with prolongred and chronic CNS-infections. Acta Paediatr Scand 70:91–99

    Google Scholar 

  23. Stephani U, Rating D, Korinthenberg R, Siemes H, Riehm H, Hanefeld F (1983) Radiation-related disturbance of blood-brain barrier during therapy of acute lymphoblastic leukemia. Lancet II:1036–1037

    Google Scholar 

  24. Tibbling G, Link H, Öhman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37:385–390

    Google Scholar 

  25. Unger C, Eibl H, von Heyden H-W, Krisch B, Nagel GA (1985) Blut-Hirnschranke und Penetration von Zytostatika. Klin Wochenschr 63:565–571

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ludwig, R., Kretzmann, R., Burger, R. et al. Veränderungen der Blut-Liquorschranke für Serumproteine bei Kindern mit akuter lymphatischer Leukämie. Klin Wochenschr 65, 76–81 (1987). https://doi.org/10.1007/BF01745478

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01745478

Key words

Navigation